Quest broadens access to COVID-19 multiplex tests as flu cases rise

Quest Diagnostics is broadening access to its multiplex test to detect flu and COVID-19, letting patients self-collect samples for the test at its 1,600 testing centers across the U.S. Previously, patients had to make an appointment at a testing site, where they were swabbed by a clinician.